Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers

Lung Cancer

Volumn 66, Issue 2, 2009, Pages 205-210

  Sun, Joo Sung ^a   Park, Kyung Joo ^a   Sheen, Seung Soo ^a,b   Yoon, Joon Kee ^a   Yoon, Seok Nam ^a   Lee, Kyi Beom ^a   Hwang, Sung Chul ^a  

^a Ajou University School of Medicine   (South Korea)

^b Clinical Epidemiology and Biostatistics in Clinical Trial Center   (South Korea)

Author keywords

Carcinoma; Fluorodeoxyglucose F18; Lung neoplasms; Non small cell lung; Tomography; X ray computed

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CANCER DIAGNOSIS; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350303284     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.01.009     Document Type: Article

References (24)

1. Bruzzi J.F., and Munden R.F. PET/CT imaging of lung cancer. J Thorac Imaging 21 (2006) 123-136
2. Fritscher-Ravens A., Bohuslavizki K.H., Brandt L., Bobrowski C., Lund C., Knofel W.T., et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest 123 (2003) 442-451
3. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
4. Sun Z., and Yang P. Refining prognosis in non-small-cell lung cancer. N Engl J Med 356 (2007) 189-190 [author reply 190-181]
5. Rena O., Papalia E., Ruffini E., Casadio C., Filosso P.L., Oliaro A., et al. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung. Eur J Cardiothorac Surg 23 (2003) 409-414
6. Travis W.D., Brambilla E., Muller-Hermelink H.K., and Harris C.C. World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart (2004), International Agency for Research on Cancer Press, Lyon
7. Aquino S.L., Halpern E.F., Kuester L.B., and Fischman A.J. FDG-PET and CT features of non-small cell lung cancer based on tumor type. Int J Mol Med 19 (2007) 495-499
8. Laskin J.J., Sandler A.B., and Johnson D.H. Redefining bronchioloalveolar carcinoma. Semin Oncol 32 (2005) 329-335
9. Wong C.Y., Nunez R., Bohdiewicz P., Welsh R.J., Chmielewski G.W., Ravikrishnan K.P., et al. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET. Eur J Nucl Med 28 (2001) 1702-1705
10. Greiner M., Pfeiffer D., and Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med 45 (2000) 23-41
11. Ahuja V., Coleman R.E., Herndon J., and Patz Jr. E.F. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 83 (1998) 918-924
12. Dhital K., Saunders C.A., Seed P.T., O'Doherty M.J., and Dussek J. [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 18 (2000) 425-428
13. Patz Jr. E.F., Connolly J., and Herndon J. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. AJR Am J Roentgenol 174 (2000) 769-774
14. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., De Leyn P.R., Verbeken E.K., Deneffe G.J., et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 17 (1999) 3201-3206
15. Higashi K., Ueda Y., Yagishita M., Arisaka Y., Sakurai A., Oguchi M., et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 41 (2000) 85-92
16. Higashi K., Ueda Y., Seki H., Yuasa K., Oguchi M., Noguchi T., et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 39 (1998) 1016-1020
17. Heikkila L., Mattila P., Harjula A., Suomalainen R.J., and Mattila S. Tumour growth rate and its relationship to prognosis in bronchiolo-alveolar and pulmonary adenocarcinoma. Ann Chir Gynaecol 74 (1985) 210-214
18. Heyneman L.E., and Patz E.F. PET imaging in patients with bronchioloalveolar cell carcinoma. Lung Cancer 38 (2002) 261-266
19. Kim B.T., Kim Y., Lee K.S., Yoon S.B., Cheon E.M., Kwon O.J., et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 170 (1998) 935-939
20. Yap C.S., Schiepers C., Fishbein M.C., Phelps M.E., and Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma?. Eur J Nucl Med Mol Imaging 29 (2002) 1166-1173
21. Gandara D.R., Aberle D., Lau D., Jett J., Akhurst T., Heelan R., et al. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. J Thorac Oncol 1 (2006) S20-S26
22. Kim H.Y., Shim Y.M., Lee K.S., Han J., Yi C.A., and Kim Y.K. Persistent pulmonary nodular ground-glass opacity at thin-section CT: histopathologic comparisons. Radiology 245 (2007) 267-275
23. Libby D.M., Smith J.P., Altorki N.K., Pasmantier M.W., Yankelevitz D., and Henschke C.I. Managing the small pulmonary nodule discovered by CT. Chest 125 (2004) 1522-1529
24. Nakata M., Saeki H., Takata I., Segawa Y., Mogami H., Mandai K., et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 121 (2002) 1464-1467